AUG 07, 2020 7:41 AM PDT

How Down Syndrome genes safeguard against solid tumors

Are people with Down syndrome protected from developing solid tumors in some way? So suggests new research published in Scientific Reports, explaining that the same set of genes responsible for poor muscle development and heart valve dysfunction could protect against the growth of solid tumors. The research comes from scientists at Stanley Manne Children's Research Institute from Ann & Robert H. Lurie Children's Hospital of Chicago.

Down syndrome is a congenital genetic disorder caused by trisomy 21 (T21) that is associated with cognitive impairment, muscle hypotonia, heart defects – and, apparently, a low incidence of solid tumor formation.

"Our promising preliminary data carries strong potential for ultimately developing gene-targeted therapies to inhibit solid tumor growth in the general population," says co-lead author Yekaterina Galat. "Our findings may also provide gene targets for therapies aimed at alleviating the clinical abnormalities in people with Down syndrome."

In conducting this study, Galat and co-lead author Mariana Perepitchka made induced pluripotent stem cells from skin samples from people with Down syndrome. The stem cells were then differentiated into endothelial cells and mesodermal cells. It was during this process that Galat and Perepitchka noticed the down-regulated genes that play a role in the abnormal muscle development and heart problems that are associated with the syndrome. But more telling was the role that these down-regulated genes play in solid tumor formation and growth.

They say that the decreased expression of these genes impeded cell movement, slowed proliferation and reduced inflammatory response, ultimately making it hard for solid tumors to form and grow. Upon observing this discovery, the researchers followed-up their finding by running genome-wide analyses from publicly available data from 11,000 patients.

"When we performed genomic analyses comparing mesodermal and endothelial cell lines, we were surprised to find that trisomy 21 impacted gene expression across the entire genome. Furthermore, the decreased expression of the genes we studied was consistent, and the large extent of their down-regulation was notable as well," says Perepitchka. "This significant down-regulation potentially creates conditions that are opposite of what solid tumors would need to take hold. So, in a way, Down syndrome provides us with a non-traditional lens to study cancer development."

Photo: Pixabay

"We still need to validate our findings in an animal model," says senior author Vasil Galat, PhD, Director of Human iPS and Stem Cell Core at Manne Research Institute at Lurie Children's and Research Assistant Professor of Pathology at Northwestern University Feinberg School of Medicine. "The potential for gene-targeted therapies is very exciting, especially since it could help individuals born with Down syndrome and the general population battling cancer."

Sources: Scientific Reports, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 15, 2020
Cancer
Traditional Medicine Reveals a New Anti-Cancer Drug
JUL 15, 2020
Traditional Medicine Reveals a New Anti-Cancer Drug
The art of traditional eastern medicine dates back thousands of years. It uses many unproven remedies, and many consider ...
JUL 28, 2020
Clinical & Molecular DX
Cancer Diagnostics Go Skin Deep
JUL 28, 2020
Cancer Diagnostics Go Skin Deep
The average adult human has between 16 and 22 square feet of skin. This multifaceted organ serves a multitude of functio ...
JUL 27, 2020
Genetics & Genomics
Pediatric Cancer Mutations Show the Importance of Non-Coding Regions
JUL 27, 2020
Pediatric Cancer Mutations Show the Importance of Non-Coding Regions
A new computational tool was created by scientists at CHOP and it has now revealed new mutations that are linked to five ...
AUG 16, 2020
Cancer
Cancer mapping shows health disparities in remote areas
AUG 16, 2020
Cancer mapping shows health disparities in remote areas
Scientists mapping cancer statistics have developed a new mathematical model to track health inequalities relating to th ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
Loading Comments...